分子診断の世界市場予測（～2023年）...市場調査レポートについてご紹介

【英文タイトル】Molecular Diagnostics Market by Application (Infectious Disease (Hepatitis, HIV), Oncology, Genetic Testing), Technology (PCR, DNA Sequencing & NGS), End User (Hospital/Academic Laboratory), Product & Service (Reagent, Software) - Global Forecast to 2023

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要（一部）】

TABLE OF CONTENTS

1 INTRODUCTION 22
1.1 OBJECTIVES OF THE STUDY 22
1.2 MARKET DEFINITION 22
1.2.1 MARKETS COVERED 23
1.2.2 YEARS CONSIDERED FOR THE STUDY 24
1.3 CURRENCY 24
1.4 LIMITATIONS 24
1.5 STAKEHOLDERS 25
2 RESEARCH METHODOLOGY 26
2.1 PRIMARY DATA 27
2.1.1 KEY DATA FROM PRIMARY SOURCES 27
2.1.2 KEY INDUSTRY INSIGHTS 28
2.2 SECONDARY DATA 29
2.2.1 KEY DATA FROM SECONDARY SOURCES 29
2.3 MARKET SIZE ESTIMATION 30
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 32
2.4.1 ASSUMPTIONS FOR THE STUDY 33
3 EXECUTIVE SUMMARY 34
4 PREMIUM INSIGHTS 39
4.1 MOLECULAR DIAGNOSTICS: MARKET OVERVIEW 39
4.2 MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY AND REGION, 2018 40
4.3 MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT AND SERVICE,
2018 VS. 2023 (USD BILLION) 40
4.4 MOLECULAR DIAGNOSTICS MARKET, BY END USER 41
5 MARKET OVERVIEW 42
5.1 INTRODUCTION 42
5.2 MARKET DYNAMICS 42
5.2.1 DRIVERS 43
5.2.1.1 High prevalence of infectious diseases and various types of cancers 43
5.2.1.2 Increasing awareness and acceptance of personalized medicine
and companion diagnostics 43
5.2.1.3 Growth in the biomarker identification market and advancements
in molecular techniques 43
5.2.2 RESTRAINTS 44
5.2.2.1 Complex regulatory frameworks delaying the approval of new molecular diagnostic tests 44
5.2.3 OPPORTUNITIES 44
5.2.3.1 Advances in genomics and proteomics 44
5.2.3.2 Growth opportunities in emerging markets 45
5.2.4 CHALLENGES 46
5.2.4.1 Dearth of trained professionals limiting the appropriate use
of new molecular diagnostic technologies 46
6 MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE 47
6.1 INTRODUCTION 48
6.2 REAGENTS & KITS 48
6.3 INSTRUMENTS 51
6.4 SERVICES & SOFTWARE 54
7 MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 58
7.1 INTRODUCTION 59
7.2 POLYMERASE CHAIN REACTION (PCR) 60
7.3 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY (INAAT) 63
7.4 DNA SEQUENCING & NEXT-GENERATION SEQUENCING (NGS) 66
7.5 IN SITU HYBRIDIZATION 69
7.6 DNA MICROARRAY 72
7.7 OTHER TECHNOLOGIES 74
8 MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 78
8.1 INTRODUCTION 79
8.2 INFECTIOUS DISEASES 80
8.2.1 HEPATITIS 84
8.2.2 HIV 85
8.2.3 CT/NG 86
8.2.4 HAIS 87
8.2.5 HPV 88
8.2.6 TUBERCULOSIS 89
8.2.7 INFLUENZA 90
8.2.8 OTHER INFECTIOUS DISEASES 91
8.3 ONCOLOGY 92
8.3.1 BREAST CANCER 95
8.3.2 COLORECTAL CANCER 95
8.3.3 LUNG CANCER 96
8.3.4 PROSTATE CANCER 97
8.3.5 OTHER CANCERS 98
8.4 GENETIC TESTS 99
8.5 OTHER APPLICATIONS 102
 
9 MOLECULAR DIAGNOSTICS MARKET, BY END USER 105
9.1 INTRODUCTION 106
9.2 HOSPITAL & ACADEMIC LABORATORIES 107
9.3 REFERENCE LABORATORIES 110
9.4 OTHER END USERS 113
10 MOLECULAR DIAGNOSTICS MARKET, BY REGION 116
10.1 INTRODUCTION 117
10.2 NORTH AMERICA 118
10.2.1 US 121
10.2.2 CANADA 124
10.3 EUROPE 126
10.3.1 GERMANY 129
10.3.2 FRANCE 132
10.3.3 ITALY 134
10.3.4 SPAIN 136
10.3.5 UK 138
10.3.6 REST OF EUROPE 141
10.4 ASIA PACIFIC 143
10.4.1 JAPAN 147
10.4.2 CHINA 149
10.4.3 AUSTRALIA 152
10.4.4 INDIA 154
10.4.5 ROAPAC 156
10.5 REST OF THE WORLD 159
10.5.1 LATIN AMERICA 161
10.5.1.1 Brazil 163
10.5.1.2 Mexico 166
10.5.1.3 Rest of Latin America 168
10.5.2 MIDDLE EAST & AFRICA 170
11 COMPETITIVE LANDSCAPE 173
11.1 OVERVIEW 173
11.2 MARKET SHARE ANALYSIS 174
11.3 MOLECULAR DIAGNOSTICS MARKET COMPETITIVE SHARE ANALYSIS, BY APPLICATION 175
11.3.1 MARKET SHARE ANALYSIS FOR INFECTIOUS DISEASE APPLICATIONS 175
11.3.2 MOLECULAR DIAGNOSTICS MARKET SHARE ANALYSIS, BY TECHNOLOGY 176
11.3.2.1 POLYMERASE CHAIN REACTION (PCR) 176
11.3.2.2 DNA SEQUENCING AND NGS 176
11.3.2.3 IN SITU HYBRIDIZATION (ISH) 177
 
11.4 COMPETITIVE SITUATION AND TRENDS 177
11.4.1 NEW PRODUCT LAUNCHES AND APPROVALS, 2016–2018 177
11.4.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2016–2018 178
11.4.3 ACQUISITIONS AND MERGERS 179
11.4.4 EXPANSIONS 179
12 COMPANY PROFILES 180
Business Overview, Products Offered, Services Offered, Recent Developments, MnM View
12.1 ABBOTT LABORATORIES 180
12.2 AGILENT TECHNOLOGIES 184
12.3 BECTON, DICKINSON AND COMPANY 189
12.4 BIOMÉRIEUX SA 194
12.5 DANAHER CORPORATION 198
12.6 DIASORIN 203
12.7 GRIFOLS 207
12.8 HOLOGIC 210
12.9 ILLUMINA 213
12.10 QIAGEN 217
12.11 ROCHE DIAGNOSTICS 222
12.12 SIEMENS AG 226
12.13 THERMO FISHER SCIENTIFIC 229
*Details might not be captured in case of unlisted companies.
13 APPENDIX 234
13.1 DISCUSSION GUIDE 234
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 237
13.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 239
13.4 AVAILABLE CUSTOMIZATIONS 240
13.5 RELATED REPORTS 240
13.6 AUTHOR DETAILS 241

【レポート販売概要】

■ タイトル：分子診断の世界市場予測（～2023年）
■ 英文：Molecular Diagnostics Market by Application (Infectious Disease (Hepatitis, HIV), Oncology, Genetic Testing), Technology (PCR, DNA Sequencing & NGS), End User (Hospital/Academic Laboratory), Product & Service (Reagent, Software) - Global Forecast to 2023
■ 発行日：2018年5月24日
■ 調査会社：MarketsandMarkets
■ 商品コード：MD2521
■ 調査対象地域：グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業（メーカー、ベンダー）、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。

Follow:

RSS [PRニュース]